Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare morphologic variant of esophageal squamous cell carcinoma. Histologically, it is composed of closely packed cells with hyperchromatic nuclei and scant basophilic cytoplasm. It has a similar prognosis to the conventional squamous cell carcinoma of the esophagus. (WHO)
Biomarker and diagnostic research for esophageal basaloid carcinoma has been reported in the published literature.
No clinical trials have been registered for esophageal basaloid carcinoma.
14 publications have been identified in PubMed for esophageal basaloid carcinoma. Research spans Basic Science / Preclinical (36%), Case Report / Case Series (29%), and Diagnostic / Biomarker (21%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 5 | 36% |
Data assembled from 2 of 12 sources · Last updated Sep 21, 2026, 12:14 AM UTC
4 |
29% |
Testing and diagnosis research | 3 | 21% |
Clinical study results | 1 | 7% |
Disease patterns and progression | 1 | 7% |
Nie L (2026). [PMID: 41995820](https://pubmed.ncbi.nlm.nih.gov/41995820/). *Virchows Arch*. [Basic Science / Preclinical]
Yuan Y (2026). [PMID: 41410721](https://pubmed.ncbi.nlm.nih.gov/41410721/). *Esophagus : official journal of the Japan Esophageal Society*. [Epidemiology / Natural History]
Xiao YH (2026). [PMID: 41956748](https://pubmed.ncbi.nlm.nih.gov/41956748/). *Zhonghua Bing Li Xue Za Zhi*. [Diagnostic / Biomarker]
Claus J (2026). [PMID: 41561668](https://pubmed.ncbi.nlm.nih.gov/41561668/). *Gynecologic oncology reports*. [Basic Science / Preclinical]
Reynders C (2025). [PMID: 40738325](https://pubmed.ncbi.nlm.nih.gov/40738325/). *Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc*. [Case Report / Case Series]
Jiang D (2025). [PMID: 39793931](https://pubmed.ncbi.nlm.nih.gov/39793931/). *Human pathology*. [Basic Science / Preclinical]
Jiang D (2025). [PMID: 40301136](https://pubmed.ncbi.nlm.nih.gov/40301136/). *Virchows Archiv : an international journal of pathology*. [Basic Science / Preclinical]
Tian Q (2025). [PMID: 38258792](https://pubmed.ncbi.nlm.nih.gov/38258792/). *Revista espanola de enfermedades digestivas*. [Case Report / Case Series]
Qi X (2025). [PMID: 40094021](https://pubmed.ncbi.nlm.nih.gov/40094021/). *Frontiers in oncology*. [Case Report / Case Series]
Sato K (2025). [PMID: 39845272](https://pubmed.ncbi.nlm.nih.gov/39845272/). *Case reports in surgery*. [Case Report / Case Series]
AI-curated news mentioning esophageal basaloid carcinoma
Updated Aug 4, 2026
A case report highlights the rare occurrence of synchronous metastatic esophageal squamous cell carcinoma and acute myeloid leukemia. This unique presentation underscores the complexity of diagnosing and treating patients with multiple malignancies.
A report details the use of immune checkpoint inhibitor-based chemotherapy in three cases of advanced esophageal squamous cell carcinoma producing granulocyte-colony stimulating factor. This study contributes to the understanding of treatment options for this rare cancer subtype.
A case report details a patient with basaloid urothelial carcinoma who presented with paraneoplastic hypercalcemia and leukocytosis. This study contributes to the understanding of the clinical manifestations associated with this rare cancer type.